Clarity Pharmaceuticals Ltd (ASX:CU6)
Australia
· Delayed Price · Currency is AUD 2.520
+0.130 (5.44%)
Jun 27, 2025, 4:17 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 700.55 million as of June 27, 2025. Its market cap has decreased by -56.91% in one year.
Market Cap
700.55M
Enterprise Value
589.35M
Revenue
10.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.52
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 700.55M, an increase of 82.34%. That is a compound annual growth rate of 16.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 810.11M | -39.44% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 115.46B |
| Pro Medicus | 29.01B |
| Cochlear | 19.43B |
| Sonic Healthcare | 12.66B |
| Ramsay Health Care | 8.23B |
| Telix Pharmaceuticals | 8.23B |
| Ansell | 4.39B |
| Regis Healthcare | 2.29B |